A skin microbiopsy device developed by researchers at The University of Queensland, that takes tissue samples smaller than 0.5mm in diameter, could change the way skin cancers and other skin conditions are diagnosed and monitored.
19 April 2022
A strategic partnership between The University of Queensland and global pharmaceutical company LEO Pharma will investigate the genetic causes of squamous cell carcinoma, the world’s second most common skin cancer.
17 December 2013
